Pfizer saw U.S. Comirnaty sales drop to $870 million in the recently completed third quarter from $1.16 billion in the same time frame last year. That came after vaccine sales rose the first two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback